Literature DB >> 18392338

Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).

Eugenia Rota1, Mario Bazzan, Giovanni Fantino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392338     DOI: 10.1160/TH07-09-0573

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  23 in total

1.  Fondaparinux-associated heparin-induced thrombocytopenia.

Authors:  Micah Burch; Barry Cooper
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-01

Review 2.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

5.  Thrombocytopenia during fondaparinux prophylaxis: HIT or something different?

Authors:  Giuseppe Re; Cristina Legnani
Journal:  Intern Emerg Med       Date:  2010-05-05       Impact factor: 3.397

6.  A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux.

Authors:  Aimon C Miranda; Jennifer L Donovan; Maichi T Tran; Joel M Gore
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

7.  Successful use of fondaparinux in a patient with a mechanical heart valve replacement and a history of heparin-induced thrombocytopenia.

Authors:  Tia L Corbett; Kathy S Elher; Candice L Garwood
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

Review 8.  Heparin-induced thrombocytopenia.

Authors:  Gowthami M Arepally; Thomas L Ortel
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

Review 9.  Heparin-induced thrombocytopenia and cerebral venous sinus thrombosis: case report and literature review.

Authors:  Mark J Fesler; Michael H Creer; John M Richart; Randall Edgell; Necat Havlioglu; Gershom Norfleet; Salvador Cruz-Flores
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 10.  Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).

Authors:  Zheng Cai; Zhiqiang Zhu; Mark I Greene; Douglas B Cines
Journal:  Autoimmun Rev       Date:  2016-03-09       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.